
Celsius Holdings Inc. (NASDAQ:CELH – Free Report) – Analysts at B. Riley decreased their Q4 2025 earnings estimates for shares of Celsius in a research note issued on Friday, November 7th. B. Riley analyst J. Van. Sinderen now forecasts that the company will post earnings per share of $0.11 for the quarter, down from their prior forecast of $0.13. B. Riley currently has a “Buy” rating and a $75.00 target price on the stock. The consensus estimate for Celsius’ current full-year earnings is $0.89 per share. B. Riley also issued estimates for Celsius’ FY2026 earnings at $1.26 EPS and FY2027 earnings at $1.68 EPS.
Celsius (NASDAQ:CELH – Get Free Report) last issued its quarterly earnings data on Thursday, November 6th. The company reported $0.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.14. The firm had revenue of $725.11 million during the quarter, compared to the consensus estimate of $703.68 million. Celsius had a return on equity of 36.88% and a net margin of 7.91%.The firm’s quarterly revenue was up 172.9% compared to the same quarter last year.
Get Our Latest Stock Analysis on CELH
Celsius Price Performance
Shares of Celsius stock opened at $43.73 on Monday. Celsius has a twelve month low of $21.10 and a twelve month high of $66.74. The business’s fifty day moving average price is $57.78 and its 200 day moving average price is $49.57. The company has a current ratio of 2.11, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $11.28 billion, a P/E ratio of 118.19, a PEG ratio of 1.25 and a beta of 1.34.
Insider Buying and Selling at Celsius
In other news, major shareholder William H. Milmoe sold 40,000 shares of Celsius stock in a transaction that occurred on Friday, October 10th. The shares were sold at an average price of $62.50, for a total value of $2,500,000.00. Following the transaction, the insider owned 221,245 shares of the company’s stock, valued at $13,827,812.50. This trade represents a 15.31% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Paul H. Storey sold 7,500 shares of the company’s stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $60.93, for a total transaction of $456,975.00. Following the sale, the insider directly owned 37,550 shares of the company’s stock, valued at approximately $2,287,921.50. This represents a 16.65% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 57,500 shares of company stock worth $3,581,975 over the last 90 days. Insiders own 2.55% of the company’s stock.
Institutional Investors Weigh In On Celsius
Several hedge funds and other institutional investors have recently made changes to their positions in CELH. Assenagon Asset Management S.A. increased its stake in Celsius by 9,579.6% during the second quarter. Assenagon Asset Management S.A. now owns 828,860 shares of the company’s stock valued at $38,451,000 after acquiring an additional 820,297 shares during the period. Belpointe Asset Management LLC acquired a new stake in shares of Celsius during the 2nd quarter worth approximately $835,000. SWS Partners bought a new stake in shares of Celsius during the second quarter valued at approximately $1,719,000. Polianta Ltd acquired a new position in shares of Celsius in the second quarter valued at $1,428,000. Finally, CWM LLC lifted its position in Celsius by 182.1% in the second quarter. CWM LLC now owns 20,698 shares of the company’s stock worth $960,000 after purchasing an additional 13,362 shares during the period. 60.95% of the stock is owned by institutional investors and hedge funds.
About Celsius
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Recommended Stories
- Five stocks we like better than Celsius
- Investing In Automotive Stocks
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
- Stock Market Sectors: What Are They and How Many Are There?
- Strategy Shares Plunge as Bitcoin Retreats—More Pain Ahead?
- 3 Grocery Stocks That Are Proving They Are Still Essential
- BigBear.ai Stock Is Range-Bound—Wall Street Isn’t Buying the Hype
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.
